Darnisha Harrison, Louisiana State University grad and founder and CEO of Georgia-based Ennaid Therapeutics, LLC
Stories this photo appears in:
Black-Owned Laboratory Uses Artificial Intelligence-Based Drug Discovery Platform to Develop Treatment for COVID-19
NNPA NEWSWIRE — “We anticipate the clinical trials could start within 90 days. The clinical trial itself could take a month. We feel quite optimistic that in the 120-day window, when our clinical material would be ready, we could have a drug that could be safe and effective at treating COVID-19.”
